
Aydin H. Harston
Professional Bio
Aydin Harston combines his love for science and technology with legal expertise to advocate for his clients in all matters necessary to grow, protect, and defend their businesses. With a Ph.D. in biochemistry and numerous scientific and legal publications, Aydin seeks to produce creative and effective approaches to achieve his clients' goals as efficiently as possible.
Supreme Court to Address ‘Skinny Label’ Patent Disputes
Biosimilars Law Bulletin ·
FDA Proposes Sweeping Changes to Accelerate Biosimilar Development
Biosimilars Law Bulletin ·
One is the Loneliest Number: Can Single-Patient Case Studies Provide an Enabling Basis for Patent Claims?
Biosimilars Law Bulletin ·
Beyond Guinea Pigs: Patent Risks and Opportunities in AI-Enabled Drug Development
Biosimilars Law Bulletin ·
Biosimilars Boom: 2025’s Fast Track Approvals Look to Reshape Healthcare
Biosimilars Law Bulletin ·